SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Catalytica Energy Systems, Inc. (CESI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WTMHouston who wrote (1400)10/5/1999 10:24:00 AM
From: WTMHouston  Read Replies (1) of 1514
 
Another new contract
Troy
siliconinvestor.com

Catalytica to Produce Worldwide Supply of Rhone-Poulenc Rorer's Synercid IV
MOUNTAIN VIEW, Calif.--(BW HealthWire)--Oct. 5, 1999--Catalytica Pharmaceuticals, Inc., a subsidiary of Catalytica, Inc. (Nasdaq: CTAL), announced today that it will produce the worldwide supply of Synercid(R)IV for Rhone-Poulenc Rorer (NYSE: RPR).

"RPR's choice of Catalytica for the manufacture of Synercid underscores our uncompromising commitment to quality and regulatory expertise. These competitive advantages have enabled us to attract a growing number of leading firms with strategically important products," stated Dr. Gabriel Cipau, President and CEO of Catalytica Pharmaceuticals. "We also know that time to market is critical to our customers. We have been working closely with RPR under a development agreement for the past several months to qualify our sterile facility for the production of Synercid in the United States and Europe."

* * * * Since the acquisition of the Greenville Facility from Glaxo Wellcome in 1997, Catalytica has entered into over 40 new agreements for the development and manufacture of products for various pharmaceutical and biotech companies. In anticipation of additional business, it has expanded its chemical manufacturing facility and is currently expanding its sterile facility. It is the largest independent, fully integrated drug development and manufacturing supplier in the world.

Etc....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News